Skip to main content
. 2021 Mar;55(2):154–158. doi: 10.5152/j.aott.2021.20115

Table 1.

Descriptive analysis of demographic characteristics of the patients and tumor characteristics

n (%)
Age (years) Min-max (median) 1–71 (44)
Mean±SD 41.96±21.88
Sex Female 10 (40.0)
Male 15 (60.0)
Diagnosis Osteosarcoma 9 (36.0)
Ewing sarcoma 3 (9.0)
Pleomorphic sarcoma 3 (9.0)
Chondrosarcoma 2 (8.0)
Fibrosarcoma 2 (8.0)
Dermatofibrosarcoma protuberans 1 (4.0)
Leimyosarcoma 1 (4.0)
Myofibroblastic sarcoma 1 (4.0)
Myxofibrosarcoma 1 (4.0)
Rabdomyosarcoma 1 (4.0)
Synovial Sarcoma 1 (4.0)
Tumor localization Upper extremity 6 (24.0)
Lower extremity 19 (76.0)
Tumor depth Superficial 0 (0.0)
Deep 25 (100.0)
Tumor size (cm) Min-max (median) 4–30 (9)
Mean±SD 10.20±5.45
Tumor grade Grade 1 4 (16.0)
Grade 2 3 (12.0)
Grade 3 18 (72.0)
Surgical margin Wide 16 (64.0)
Marginal 5 (20.0)
Intralesional 4 (16.0)
Closure of wound Primary 18 (72.0)
STSG 3 (12.0)
Free flap 4 (16.0)
Indications of amputation Oncological indications
Local recurrence 18 (72.0)
Non-oncological indications
Prosthetic infection 5 (20.0)
Mechanic failure 1 (4.0)
Skin necrosis 1 (4.0)
Number of operations before amputation Min-max (median) 1–4 (2)
Mean±SD 2±0.76
Amputation decision for oncological indications 1st local recurrence 4 (22.2)
2nd local recurrence 11 (61.1)
>2nd local recurrence 3 (16.7)
Metastasis before amputation Yes 13 (52.0)
No 12(48.0)
Metastasis at follow-up Yes 22 (88.0)
No 3 (12.0)
Survival status Alive 11 (44.0)
Dead 14 (56.0)
Follow-up (month) Min-max (median) 6–125 (27)
Mean±SD 39.88±31.59

SD: standard deviation; STSG: split thickness skin graft.